2008
A trusted advisor in clinical trials
Suvoda is a global clinical trial technology company helping sponsors, CROs, and sites move complex studies forward with a real-time platform, purposeful products, rigorous processes, and experienced teams built for the most critical moments in a trial.
Trials conducted
with 65% in oncology, rare disease, and CNS
Countries supported
with trial sites in
thousands of locations
Patents
patents recognizing technology innovation
Empowering confident decisions and calm action in the moments that matter most
Clinical trials are complex, highly coordinated, and deeply consequential. In the moments when decisions need to be made and actions need to align, the people running and participating in studies need technology and support they can trust.
Suvoda brings together RTSM/IRT, eCOA, Patient Payments, Travel, eConsent, Scheduling, Site Payments, and Budgeting & Benchmarking to help sponsors, CROs, sites, and patients navigate complexity with greater confidence.
Together, we Trial wisely.
Suvoda means “the dawn of well-being”
Suvoda was built on a shared promise: to ease the experience of those running and participating in clinical trials, while providing greater insights to help sponsors, CROs, sites, and patients make more informed decisions. Our name, derived from Sanskrit, reflects this commitment to improving every step of the trial journey.
Sanskrit nods to our founder and CEO’s heritage—it is the ancient root of Sinhalese, his native language. Our name represents both the depth of our mission and the global perspective that continues to guide us.
We see every moment, in every trial, as a milestone. Here are a few of ours:

Suvoda means “the dawn of well-being”
Derived from Sanskrit, our name reflects Suvoda’s commitment to improving the clinical trial journey for everyone involved. It nods to our founder and CEO’s heritage, as Sanskrit is the ancient root of Sinhalese, his native language. For us, our name represents the mission and global perspective that continue to guide us.
At Suvoda, our shared purpose to advance human health and the values we live by guide how we support patients, partners, and each other
For patients. For progress.
We make trials smarter and more patient-centered to accelerate breakthroughs in human health. Empathy shapes our approach and informs how we simplify trial complexity, so sponsors can focus on the science, sites on the patient, and patients on their health. We each contribute our strengths to move people and progress forward.
Trusted for excellence.
Holding ourselves to the highest standards, we do right by the people who depend on us. We aim for clarity, accuracy, and consistency in everything we do, and we safeguard trial integrity and patient safety throughout each study. Trust grows from the care, discipline, and accountability we bring to our work.
Own it, together.
Aligned in direction, committed in effort, we achieve more through our strength as a team. We step up for one another, take responsibility for our part, and look for ways to contribute to the whole. We share ideas freely, listen with care, and value the perspectives that make our work stronger.
Keep evolving.
With an open mindset and desire to learn, we question, explore, and adapt to create new possibilities. We look beneath the surface to understand root causes, welcome new insights, and create space where it’s safe to ask questions and challenge ideas. Curiosity and learning keep us moving forward.
We see every moment, in every trial, as a milestone. Here are a few of ours:
2000
2011
2014
Card services deployed in Europe
2018
1 million participants using ClinCard
Surpassed 1,000 trials
2010
2013
Suvoda founded in Philadelphia
Released IRT 1.0
2014
Signed first customer contract
Opened Bucharest office
2016
2019
2020
1,000 clients
$3 billion in payments
Budget tool launched
2021
Acquired and financially backed by leading private equity firm
Surpassed 2,000 trials
2020
2020
2021
2022
eConsent general availability
Surpassed 1,000 trials
2023
Released the Suvoda Platform
eCOA general availability
2024
Released ePatient 1.0
Surpassed 1,500 trials
2025